Dr Reddy'S Laboratories Ltd

RDY

Equity

ISIN null / Valor 1221723

New York Stock Exchange, Inc (2026-10-02)

USD 12.25%

Dr Reddy'S Laboratories Ltd
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Dr. Reddy's Laboratories Ltd is a global pharmaceutical company headquartered in India, engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products. The company operates through various business segments including Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars, and over-the-counter (OTC) pharmaceutical products. Dr. Reddy's has a strong focus on meeting patient needs in several therapeutic areas such as gastroenterology, cardiovascular, diabetology, oncology, pain management, and dermatology. In addition to its existing product portfolio, the company is actively developing a pipeline of novel small molecules in immuno-oncology and working on differentiated products that aim to improve upon existing therapeutic agents. Furthermore, Dr. Reddy's is investing in emerging fields like digital therapeutics, cell, and gene therapies, indicating its commitment to innovation and addressing unmet medical needs.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-12.9%1Y

-7.88%3Y

-7.66%5Y

Performance

26.9%1Y

135%3Y

105%5Y

Volatility